{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:21:48Z","timestamp":1786980108406,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-024-07387-4","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T11:02:28Z","timestamp":1709204548000},"page":"1999-2008","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of progesterone protocol versus gonadotropin-releasing hormone antagonist protocol in terms of preventing premature LH surge and assisted reproductive technology outcome in infertile women: a randomized controlled trial"],"prefix":"10.1007","volume":"309","author":[{"given":"Masoome","family":"Jabarpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Pouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Aleyasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Shabani Nashtaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7728-5348","authenticated-orcid":false,"given":"Aida","family":"Najafian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,29]]},"reference":[{"issue":"7","key":"7387_CR1","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1093\/humrep\/del075","volume":"21","author":"AN Andersen","year":"2006","unstructured":"Andersen AN et al (2006) Assisted reproductive technology in Europe 2002 Results generated from European registers by ESHRE. Hum Reprod 21(7):1680\u20131697","journal-title":"Hum Reprod"},{"issue":"3","key":"7387_CR2","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0015-0282(01)01973-2","volume":"76","author":"LG Westergaard","year":"2001","unstructured":"Westergaard LG et al (2001) Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study. Fertil Steril 76(3):543\u2013549","journal-title":"Fertil Steril"},{"issue":"3","key":"7387_CR3","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/humrep\/15.3.526","volume":"15","author":"C Albano","year":"2000","unstructured":"Albano C et al (2000) Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin European Cetrorelix Study Group. Hum Reprod 15(3):526\u2013531","journal-title":"Hum Reprod"},{"issue":"5","key":"7387_CR4","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/humupd\/dml020","volume":"12","author":"IE Messinis","year":"2006","unstructured":"Messinis IE (2006) Ovarian feedback, mechanism of action and possible clinical implications. Hum Reprod Update 12(5):557\u2013571","journal-title":"Hum Reprod Update"},{"issue":"3","key":"7387_CR5","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.fertnstert.2006.12.064","volume":"91","author":"EG Papanikolaou","year":"2009","unstructured":"Papanikolaou EG et al (2009) Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer. Fertil Steril 91(3):949\u2013952","journal-title":"Fertil Steril"},{"issue":"7","key":"7387_CR6","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1093\/humrep\/der126","volume":"26","author":"E Labarta","year":"2011","unstructured":"Labarta E et al (2011) Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod 26(7):1813\u20131825","journal-title":"Hum Reprod"},{"issue":"3","key":"7387_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.rbmo.2010.11.002","volume":"22","author":"I Van Vaerenbergh","year":"2011","unstructured":"Van Vaerenbergh I et al (2011) Progesterone rise on HCG day in GnRH antagonist\/rFSH stimulated cycles affects endometrial gene expression. Reprod Biomed Online 22(3):263\u2013271","journal-title":"Reprod Biomed Online"},{"key":"7387_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001750.pub4","author":"HG Al-Inany","year":"2016","unstructured":"Al-Inany HG et al (2016) Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD001750.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"7387_CR9","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1093\/humrep\/dew051","volume":"31","author":"M Toftager","year":"2016","unstructured":"Toftager M et al (2016) Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF\/ICSI cycles. Hum Reprod 31(6):1253\u20131264","journal-title":"Hum Reprod"},{"issue":"6","key":"7387_CR10","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1016\/j.fertnstert.2011.01.163","volume":"95","author":"G Griesinger","year":"2011","unstructured":"Griesinger G et al (2011) Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of\u00a0final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a \u201cfreeze-all\u201d strategy: a prospective multicentric study. Fertil Steril 95(6):2029\u20132033","journal-title":"Fertil Steril"},{"issue":"6","key":"7387_CR11","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1046\/j.1365-2265.1997.3461141.x","volume":"47","author":"E Alexandris","year":"1997","unstructured":"Alexandris E et al (1997) Changes in gonadotrophin response to gonadotrophin releasing hormone in normal women following bilateral ovariectomy. Clin Endocrinol (Oxf) 47(6):721\u2013726","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"7387_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.fertnstert.2013.09.007","volume":"101","author":"Y Kuang","year":"2014","unstructured":"Kuang Y et al (2014) Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization\/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles. Fertil Steril 101(1):105\u2013111","journal-title":"Fertil Steril"},{"issue":"2","key":"7387_CR13","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1210\/jcem-58-2-378","volume":"58","author":"MR Soules","year":"1984","unstructured":"Soules MR et al (1984) Progesterone modulation of pulsatile luteinizing hormone secretion in normal women. J Clin Endocrinol Metab 58(2):378\u2013383","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"7387_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","volume":"104","author":"Y Kuang","year":"2015","unstructured":"Kuang Y et al (2015) Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril 104(1):62-70.e3","journal-title":"Fertil Steril"},{"issue":"21","key":"7387_CR15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000909","volume":"94","author":"X Zhu","year":"2015","unstructured":"Zhu X, Zhang X, Fu Y (2015) Utrogestan as an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Medicine (Baltimore) 94(21):e909","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"7387_CR16","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00404-018-4856-8","volume":"298","author":"N Iwami","year":"2018","unstructured":"Iwami N et al (2018) New trial of progestin-primed ovarian stimulation using dydrogesterone versus a typical GnRH antagonist regimen in assisted reproductive technology. Arch Gynecol Obstet 298(3):663\u2013671","journal-title":"Arch Gynecol Obstet"},{"issue":"9","key":"7387_CR17","first-page":"671","volume":"17","author":"M Eftekhar","year":"2019","unstructured":"Eftekhar M, Hoseini M, Saeed L (2019) progesterone-primed ovarian stimulation in polycystic ovarian syndrome: an RCT. Int J Reprod Biomed 17(9):671\u2013676","journal-title":"Int J Reprod Biomed"},{"key":"7387_CR18","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3389\/fendo.2019.00796","volume":"10","author":"Q Chen","year":"2019","unstructured":"Chen Q et al (2019) Progestin vs gonadotropin-releasing hormone antagonist for the prevention of premature luteinizing hormone surges in poor responders undergoing in vitro fertilization treatment: a randomized controlled trial. Front Endocrinol (Lausanne) 10:796","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"7387_CR19","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1093\/humrep\/dez034","volume":"34","author":"R Beguer\u00eda","year":"2019","unstructured":"Beguer\u00eda R, Garc\u00eda D, Vassena R, Rodr\u00edguez A (2019) Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial. Hum Reprod 34(5):872\u2013880","journal-title":"Hum Reprod"},{"issue":"2","key":"7387_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jogoh.2018.10.008","volume":"48","author":"P Huang","year":"2019","unstructured":"Huang P, Tang M, Qin A (2019) Progestin-primed ovarian stimulation is a feasible method for poor ovarian responders undergoing in IVF\/ICSI compared to a GnRH antagonist protocol: a retrospective study. J Gynecol Obstet Hum Reprod 48(2):99\u2013102","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"4","key":"7387_CR21","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.fertnstert.2019.06.009","volume":"112","author":"S Yildiz","year":"2019","unstructured":"Yildiz S et al (2019) Comparison of a novel flexible progestin primed ovarian stimulation protocol and the flexible gonadotropin-releasing hormone antagonist protocol for assisted reproductive technology. Fertil Steril 112(4):677\u2013683","journal-title":"Fertil Steril"},{"issue":"1","key":"7387_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13048-020-00620-z","volume":"13","author":"E Mathieu d'Argent","year":"2020","unstructured":"Mathieu d\u2019Argent E et al (2020) Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols. J Ovarian Res 13(1):18","journal-title":"J Ovarian Res"},{"key":"7387_CR23","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.12659\/MSM.906602","volume":"24","author":"X Wen","year":"2018","unstructured":"Wen X et al (2018) Lipidomic components alterations of human follicular fluid reveal the relevance of improving clinical outcomes in women using progestin-primed ovarian stimulation compared to short-term protocol. Med Sci Monit 24:3357\u20133365","journal-title":"Med Sci Monit"},{"issue":"34","key":"7387_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011906","volume":"97","author":"N Wang","year":"2018","unstructured":"Wang N et al (2018) Comparison of neonatal outcomes and live-birth defects after progestin-primed ovarian stimulation versus conventional ovarian stimulation for in vitro fertilization: a large retrospective cohort study. Medicine (Baltimore) 97(34):e11906","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"7387_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12958-019-0518-3","volume":"17","author":"Q Peng","year":"2019","unstructured":"Peng Q et al (2019) Progestin-primed ovarian stimulation vs mild stimulation in women with advanced age above 40: a retrospective cohort study. Reprod Biol Endocrinol 17(1):91","journal-title":"Reprod Biol Endocrinol"},{"issue":"9","key":"7387_CR26","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002939","volume":"95","author":"Y Wang","year":"2016","unstructured":"Wang Y et al (2016) controlled ovarian stimulation using medroxyprogesterone acetate and hMG in patients with polycystic ovary syndrome treated for IVF: a double-blind randomized crossover clinical trial. Medicine (Baltimore) 95(9):e2939","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"7387_CR27","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1210\/endo-92-5-1496","volume":"92","author":"DJ Dierschke","year":"1973","unstructured":"Dierschke DJ et al (1973) Blockade by progesterone of estrogen-induced LH and FSH release in the rhesus monkey. Endocrinology 92(5):1496\u20131501","journal-title":"Endocrinology"},{"issue":"12","key":"7387_CR28","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/j.1365-2826.2007.01613.x","volume":"19","author":"B Attardi","year":"2007","unstructured":"Attardi B, Scott R, Pfaff D, Fink G (2007) Facilitation or inhibition of the oestradiol-induced gonadotrophin surge in the immature female rat by progesterone: effects on pituitary responsiveness to gonadotrophin-releasing hormone (GnRH), GnRH self-priming and pituitary mRNAs for the progesterone receptor A and B isoforms. J Neuroendocrinol 19(12):988\u20131000","journal-title":"J Neuroendocrinol"},{"issue":"1","key":"7387_CR29","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1210\/endo.131.1.1611998","volume":"131","author":"JZ Kasa-Vubu","year":"1992","unstructured":"Kasa-Vubu JZ et al (1992) Progesterone blocks the estradiol-induced gonadotropin discharge in the ewe by inhibiting the surge of gonadotropin-releasing hormone. Endocrinology 131(1):208\u2013212","journal-title":"Endocrinology"},{"key":"7387_CR30","first-page":"57","volume":"59","author":"NP Evans","year":"2002","unstructured":"Evans NP, Richter TA, Skinner DC, Robinson JE (2002) Neuroendocrine mechanisms underlying the effects of progesterone on the oestradiol-induced GnRH\/LH surge. Reprod Suppl 59:57\u201366","journal-title":"Reprod Suppl"},{"issue":"1","key":"7387_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0010-7824(95)00255-3","volume":"53","author":"O Heikinheimo","year":"1996","unstructured":"Heikinheimo O, Gordon K, Williams RF, Hodgen GD (1996) Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions. Contraception 53(1):55\u201364","journal-title":"Contraception"},{"issue":"2","key":"7387_CR32","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1210\/endo.140.2.6490","volume":"140","author":"TG Harris","year":"1999","unstructured":"Harris TG et al (1999) Progesterone can block transmission of the estradiol-induced signal for luteinizing hormone surge generation during a specific period of time immediately after activation of the gonadotropin-releasing hormone surge-generating system. Endocrinology 140(2):827\u2013834","journal-title":"Endocrinology"},{"key":"7387_CR33","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2147\/CLEP.S226414","volume":"12","author":"Q Xi","year":"2020","unstructured":"Xi Q et al (2020) Comparison between PPOS and GnRHa-long protocol in clinical outcome with the first IVF\/ICSI cycle: a randomized clinical trial. Clin Epidemiol 12:261\u2013272","journal-title":"Clin Epidemiol"},{"issue":"1","key":"7387_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12958-017-0291-0","volume":"15","author":"Q Chen","year":"2017","unstructured":"Chen Q et al (2017) Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders. Reprod Biol Endocrinol 15(1):71","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"7387_CR35","first-page":"41","volume":"18","author":"A Ghasemzadeh","year":"2019","unstructured":"Ghasemzadeh A et al (2019) Effect of oral utrogestan in comparison with cetrotide on preventing luteinizing hormone surge in IVF cycles: a randomized controlled trial. Int J Reprod Biomed 18(1):41\u201346","journal-title":"Int J Reprod Biomed"},{"key":"7387_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.702558","volume":"12","author":"S Guan","year":"2021","unstructured":"Guan S, Feng Y, Huang Y, Huang J (2021) Progestin-primed ovarian stimulation protocol for patients in assisted reproductive technology: a meta-analysis of randomized controlled trials. Front Endocrinol (Lausanne) 12:702558","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"7387_CR37","first-page":"14","volume":"14","author":"B Hossein Rashidi","year":"2020","unstructured":"Hossein Rashidi B et al (2020) Comparison of dydrogesterone and GnRH antagonists for prevention of premature LH surge in IVF\/ICSI cycles: a randomized controlled trial. J Family Reprod Health 14(1):14\u201320","journal-title":"J Family Reprod Health"},{"issue":"5","key":"7387_CR38","doi-asserted-by":"publisher","first-page":"387","DOI":"10.21037\/atm-20-1592","volume":"9","author":"X Zhu","year":"2021","unstructured":"Zhu X, Ye H, Ye J, Fu Y (2021) Progesterone protocol versus gonadotropin-releasing hormone antagonist protocol in women with polycystic ovarian syndrome undergoing in vitro fertilization treatments with frozen-thawed embryo transfer: a prospective randomized controlled trial. Ann Transl Med 9(5):387","journal-title":"Ann Transl Med"},{"issue":"1","key":"7387_CR39","doi-asserted-by":"publisher","first-page":"22732","DOI":"10.1038\/s41598-021-02227-w","volume":"11","author":"TC Huang","year":"2021","unstructured":"Huang TC et al (2021) Progestin primed ovarian stimulation using corifollitropin alfa in PCOS women effectively prevents LH surge and reduces injection burden compared to GnRH antagonist protocol. Sci Rep 11(1):22732","journal-title":"Sci Rep"},{"issue":"1","key":"7387_CR40","doi-asserted-by":"publisher","first-page":"2217263","DOI":"10.1080\/09513590.2023.2217263","volume":"39","author":"S Xu","year":"2023","unstructured":"Xu S et al (2023) Comparison the effects of progestin-primed ovarian stimulation (PPOS) protocol and GnRH-a long protocol in patients with normal ovarian reserve function. Gynecol Endocrinol 39(1):2217263","journal-title":"Gynecol Endocrinol"},{"key":"7387_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.798434","volume":"13","author":"AM Yang","year":"2022","unstructured":"Yang AM et al (2022) Progestin-primed ovarian stimulation protocol for patients with endometrioma. Front Endocrinol (Lausanne) 13:798434","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"7387_CR42","doi-asserted-by":"publisher","first-page":"7447","DOI":"10.1038\/s41598-017-07773-w","volume":"7","author":"L Wang","year":"2017","unstructured":"Wang L et al (2017) Effect of frozen embryo transfer and progestin-primed ovary stimulation on IVF outcomes in women with high body mass index. Sci Rep 7(1):7447","journal-title":"Sci Rep"},{"issue":"1","key":"7387_CR43","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12958-018-0373-7","volume":"16","author":"H Ye","year":"2018","unstructured":"Ye H et al (2018) Progestin-primed milder stimulation with clomiphene citrate yields fewer oocytes and suboptimal pregnancy outcomes compared with the standard progestin-primed ovarian stimulation in infertile women with polycystic ovarian syndrome. Reprod Biol Endocrinol 16(1):53","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"7387_CR44","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12958-023-01124-3","volume":"21","author":"AH-Y Pai","year":"2023","unstructured":"Pai AH-Y et al (2023) Progestin primed ovarian stimulation (PPOS) protocol yields lower euploidy rate in older patients undergoing IVF. Reprod Biol Endocrinol 21(1):72","journal-title":"Reprod Biol Endocrinol"},{"issue":"4","key":"7387_CR45","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/humrep\/deaa304","volume":"36","author":"AM Terho","year":"2021","unstructured":"Terho AM et al (2021) High birth weight and large-for-gestational-age in singletons born after frozen compared to fresh embryo transfer, by gestational week: a Nordic register study from the CoNARTaS group. Hum Reprod 36(4):1083\u20131092","journal-title":"Hum Reprod"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07387-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-024-07387-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-024-07387-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T01:07:25Z","timestamp":1713143245000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-024-07387-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,29]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["7387"],"URL":"https:\/\/doi.org\/10.1007\/s00404-024-07387-4","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,29]]},"assertion":[{"value":"12 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Ethics Committee of Tehran University of Medical Sciences approved the project (Ethics committee reference number: IR.TUMS.MEDICINE.REC.1399.008). Written consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}